Patents by Inventor Rohan David JOYCE

Rohan David JOYCE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230234981
    Abstract: The present invention relates to inorganic salts of nicotinic acid mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M1, M2, k, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: March 29, 2023
    Publication date: July 27, 2023
    Inventors: Michel Wathier, Roland Dolle, Sebastian Mario Marcuccio, Rohan David Joyce, Simon Tucker
  • Publication number: 20210309685
    Abstract: The present invention relates to amino acid salts of nicotinic acid mononucleotides and nicotinamide mononucleotides and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M1, M2, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: May 15, 2019
    Publication date: October 7, 2021
    Inventors: Sebastian Mario MARCUCCIO, Rohan David JOYCE, Michel WATHIER, Roland DOLLE, Simon TUCKER
  • Publication number: 20210309686
    Abstract: The present invention relates to amino acid salts of nicotinic acid and nicotinamide and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, L, M1, M2, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: August 1, 2019
    Publication date: October 7, 2021
    Applicants: Jumpstart Fertility Pty Ltd, Life Biosciences, Inc.
    Inventors: Sebastian Mario MARCUCCIO, Rohan David JOYCE, Michel WATHIER, Roland DOLLE, Simon TUCKER
  • Publication number: 20210230208
    Abstract: The present invention relates to inorganic salts of nicotinamide mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M, k, R1 and R2 are as described herein.
    Type: Application
    Filed: May 15, 2019
    Publication date: July 29, 2021
    Inventors: Sebastian Mario MARCUCCIO, Rohan David JOYCE, Michel WATHIER, Roland DOLLE, Simon TUCKER
  • Publication number: 20210196742
    Abstract: The present invention relates to amino acid salts of nicotinic acid ribosides and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein M1, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: May 22, 2019
    Publication date: July 1, 2021
    Inventors: Sebastian Mario MARCUCCIO, Rohan David JOYCE, Michel WATHIER, Roland DOLLE, Simon TUCKER
  • Publication number: 20210061841
    Abstract: The present invention relates to inorganic salts of nicotinic acid mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M1, M2, k, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: April 15, 2020
    Publication date: March 4, 2021
    Inventors: Michel WATHIER, Roland DOLLE, Sebastian Mario MARCUCCIO, Rohan David JOYCE, Simon TUCKER
  • Patent number: 10654883
    Abstract: The present invention relates to inorganic salts of nicotinic acid mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M1, M2, k, R1, R2, and R3 are as described herein.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: May 19, 2020
    Assignees: Jumpstart Fertility Pty Ltd, Life Biosciences, Inc.
    Inventors: Michel Wathier, Roland Dolle, Sebastian Mario Marcuccio, Rohan David Joyce, Simon Tucker
  • Publication number: 20190352325
    Abstract: The present invention relates to inorganic salts of nicotinic acid mononucleotides and compositions of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein A, M1, M2, k, R1, R2, and R3 are as described herein.
    Type: Application
    Filed: April 3, 2019
    Publication date: November 21, 2019
    Inventors: Michel WATHIER, Roland DOLLE, Sebastian Mario MARCUCCIO, Rohan David JOYCE, Simon TUCKER